异常蛋白质的翻译后修改会诱导蛋白质的聚合和异常沉积,介导神经退行性疾病
Wei Li1, Hong-Lian Li1, Jian-Zhi Wang1,2
1Department of Pathophysiology, School of Basic Medicine, Key Laboratory of Education Ministry of China for Neurological Disorders, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Cell & bioscience
|February 12, 2024
概括
在神经退行性疾病中,蛋白质翻译后修饰 (PPTM) 是至关重要的. 研究异常的PPTM提供了对疾病机制和阿尔茨海默氏症等疾病潜在治疗策略的见解.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 蛋白质翻译后修饰 (PPTM) 是蛋白质合成后的化学变化.
- PPTMs调节蛋白质结构,功能和相互作用,影响生物活动.
- 异常的PPTM与各种神经退行性疾病的发病有关.
研究的目的:
- 审查PPTM在神经退行性疾病中的影响.
- 讨论针对异常PPTM的治疗策略.
主要方法:
- 对PPTM和神经退行性疾病研究的文献综述.
- 在疾病模型中分析特定的PPTM (例如,酸化,泛化).
- 综合目前对PPTM在疾病机制中的作用的理解.
主要成果:
- 在阿尔茨海默氏症和帕金森氏症等疾病中,异常的PPTM有助于蛋白质聚合和神经元死亡.
- 具体的例子包括阿尔茨海默氏症中的异常 fosforylation 和帕金森症中的α-synuclein ubiquitination.
- PPTM与亨廷顿病和肌缩性侧面硬化症有关.
结论:
- 了解异常PPTM对于阐明神经退行性疾病机制至关重要.
- 针对PPTM是一个有前途的途径,可以开发新的治疗干预措施.
- 对PPTM的进一步研究可以加速开发有效的治疗方法.
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
The Proteasome
835
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
835
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Proteins: From Genes to Degradation
12.2K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
12.2K
Parkinson's Disease: Overview
546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546


